Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Acta Diabetol. 2016 Apr 22;53(5):703–708. doi: 10.1007/s00592-016-0859-8

Table 2. Medication Adverse Effects in GCK-positive Subjects.

Medication Type Hypoglycemia (symptomatic and/or confirmed) Gastrointestinal symptoms Other*
Insulin (n=33) 11 (33%) - 1 (3%)
Metformin (n=38) 3 (7.8%) 9 (24%) 1 (2.6%)
Sulfonylurea/Glinides (n=17) 7 (41%) 1 (6%) 1 (5.8%)

Data are number and percent reporting symptom out of total number treated with each type of medication.

*

allergy to insulin, malaise with sulfonyllurea, weight loss with sulfonylurea